rs56134796

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004621.6(TRPC6):​c.-218C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 472,656 control chromosomes in the GnomAD database, including 12,183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3537 hom., cov: 33)
Exomes 𝑓: 0.22 ( 8646 hom. )

Consequence

TRPC6
NM_004621.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.325

Publications

11 publications found
Variant links:
Genes affected
TRPC6 (HGNC:12338): (transient receptor potential cation channel subfamily C member 6) The protein encoded by this gene forms a receptor-activated calcium channel in the cell membrane. The channel is activated by diacylglycerol and is thought to be under the control of a phosphatidylinositol second messenger system. Activation of this channel occurs independently of protein kinase C and is not triggered by low levels of intracellular calcium. Defects in this gene are a cause of focal segmental glomerulosclerosis 2 (FSGS2). [provided by RefSeq, Mar 2009]
TRPC6 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 11-101583721-G-A is Benign according to our data. Variant chr11-101583721-G-A is described in ClinVar as Benign. ClinVar VariationId is 301918.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.253 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TRPC6NM_004621.6 linkc.-218C>T 5_prime_UTR_variant Exon 1 of 13 ENST00000344327.8 NP_004612.2 Q9Y210-1
TRPC6NM_001439335.1 linkc.-218C>T 5_prime_UTR_variant Exon 1 of 11 NP_001426264.1
TRPC6XM_047427510.1 linkc.-218C>T 5_prime_UTR_variant Exon 1 of 11 XP_047283466.1
TRPC6XM_047427509.1 linkc.-89+211C>T intron_variant Intron 1 of 12 XP_047283465.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TRPC6ENST00000344327.8 linkc.-218C>T 5_prime_UTR_variant Exon 1 of 13 1 NM_004621.6 ENSP00000340913.3 Q9Y210-1

Frequencies

GnomAD3 genomes
AF:
0.200
AC:
30391
AN:
152076
Hom.:
3538
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.466
Gnomad AMR
AF:
0.171
Gnomad ASJ
AF:
0.274
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.123
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.256
Gnomad OTH
AF:
0.220
GnomAD4 exome
AF:
0.216
AC:
69338
AN:
320462
Hom.:
8646
Cov.:
4
AF XY:
0.216
AC XY:
35448
AN XY:
164182
show subpopulations
African (AFR)
AF:
0.122
AC:
926
AN:
7614
American (AMR)
AF:
0.157
AC:
1346
AN:
8600
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
2779
AN:
10380
East Asian (EAS)
AF:
0.000128
AC:
3
AN:
23514
South Asian (SAS)
AF:
0.112
AC:
1668
AN:
14868
European-Finnish (FIN)
AF:
0.254
AC:
6269
AN:
24654
Middle Eastern (MID)
AF:
0.306
AC:
461
AN:
1508
European-Non Finnish (NFE)
AF:
0.247
AC:
51740
AN:
209744
Other (OTH)
AF:
0.212
AC:
4146
AN:
19580
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2566
5132
7698
10264
12830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.200
AC:
30380
AN:
152194
Hom.:
3537
Cov.:
33
AF XY:
0.199
AC XY:
14795
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.118
AC:
4916
AN:
41542
American (AMR)
AF:
0.171
AC:
2611
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.274
AC:
950
AN:
3468
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5156
South Asian (SAS)
AF:
0.123
AC:
596
AN:
4828
European-Finnish (FIN)
AF:
0.275
AC:
2921
AN:
10606
Middle Eastern (MID)
AF:
0.350
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
0.256
AC:
17395
AN:
67974
Other (OTH)
AF:
0.217
AC:
458
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1226
2452
3678
4904
6130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.215
Hom.:
708
Bravo
AF:
0.191
Asia WGS
AF:
0.0610
AC:
213
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 20, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
8.3
DANN
Benign
0.87
PhyloP100
0.33
PromoterAI
-0.034
Neutral
Mutation Taster
=298/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56134796; hg19: chr11-101454452; API